| Line item | Value |
|---|---|
| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets | $216.2M | $172.5M | $180.4M | $167.9M | $161.3M | $162.6M | +25.4% | |
| Inventories | $14.0M | $14.5M | $15.3M | $13.6M | $12.7M | $13.1M | -3.3% | |
| Trade Receivables | $154.7M | $127.3M | $132.8M | $123.7M | $109.5M | $107.6M | +21.5% | |
| Cash & Equivalents | $28.0M | $18.3M | $17.6M | $20.5M | $24.1M | $25.8M | +52.9% | |
| Property, Plant & Equipment | — | — | — | — | — | $92.7M | — | |
| Goodwill | $184.8M | $181.4M | $187.4M | $199.6M | $205.4M | $206.0M | +1.9% | |
| Intangible Assets | $38.4M | $39.7M | $44.0M | $49.0M | $59.4M | $68.6M | -3.3% | |
| Deferred Tax Assets | $5.4M | $6.3M | $2.3M | $779K | $2.2M | $2.1M | -14.2% | |
| Total Assets | $578.8M | $523.0M | $534.8M | $534.9M | $562.2M | $583.3M | +10.7% | |
| Liabilities | ||||||||
| Current Liabilities | $124.3M | $114.9M | $116.5M | $103.7M | $121.4M | $109.8M | +8.2% | |
| Trade Payables | $14.9M | $11.1M | $17.0M | $12.5M | $12.9M | $14.2M | +34.3% | |
| Borrowings | $178.0M | $169.6M | $190.4M | $191.3M | $202.6M | $220.2M | +4.9% | |
| Deferred Tax Liabilities | $1.3M | $2.0M | $2.6M | $6.3M | $8.4M | $8.2M | -35.9% | |
| Total Liabilities | $343.1M | $324.1M | $344.3M | $336.2M | $361.3M | $386.1M | +5.9% | |
| Equity | ||||||||
| Share Capital | $499K | $402K | $305K | $298K | $295K | $292K | +24.1% | |
| Share Premium | $256.9M | $250.8M | $247.2M | $243.0M | $238.7M | $234.6M | +2.4% | |
| Retained Earnings | $6.9M | -$10.0M | -$28.9M | -$11.5M | -$18.0M | -$21.8M | +168.6% | |
| Minority Interests | $541K | $327K | $311K | $299K | $229K | $198K | +65.4% | |
| Total Equity | $235.6M | $198.9M | $190.5M | $198.7M | $200.9M | $197.2M | +18.5% | |
New to Ticker
Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.
Sign up freeAlready have an account? Sign in
Already a member
Welcome back
Sign in to pick up where you left off, with full access to every page.
Sign in